New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, FDA regulation of peptide industry and importance of reputable providers The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Dihexa 10 MG NewHope Wellness Advisors EllieMD Dihexa Dihexa in Clinical Trials: What We've Learned So Far